Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Med Vasc ; 45(4): 198-209, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32571560

RESUMO

AIM OF THE STUDY AND PATIENTS: Direct oral anticoagulants (DOA) tend to replace antivitamins K (VKA). The incidence of major and minor hemorrhages is higher in women, a difference potentially linked to genital hemorrhages. The objective is to assess the practices and perception of general practitioners of the use of oral anticoagulant therapy in women of childbearing age. MATERIALS AND METHODS: Descriptive, observational, transversal and monocentric study. An 11-items questionnaire was sent to 900 randomized general practitioners, assessing the type of patient, the type of anticoagulant prescribed, the management of genital bleeding, and the assessment of the quality of life of anticoagulated patients. RESULTS: DOA were the most prescribed anticoagulants. Genital hemorrhage was the second leading cause of minor hemorrhage. Most doctors (60.6%) believed they were due to VKAs. 25% reported an alteration in the quality of life of patients following these genital hemorrhages and 47.5% addressed this subject in consultation. CONCLUSION: Our study suggests that, according to the general practitioners interviewed, genital hemorrhage is more frequent on VKA than on DOA in women of reproductive age, which is contradictory with the data in the literature. The probably taboo subject is rarely mentioned in consultation and is responsible for a deterioration in the quality of life in these young patients. No recommendation exists on the management of this type of genital hemorrhage in these women. An algorithm is proposed for their management.


Assuntos
Anticoagulantes/efeitos adversos , Atitude do Pessoal de Saúde , Clínicos Gerais/psicologia , Conhecimentos, Atitudes e Prática em Saúde , Saúde Reprodutiva , Hemorragia Uterina/induzido quimicamente , Saúde da Mulher , Anticoagulantes/administração & dosagem , Feminino , Humanos , Idade Materna , Qualidade de Vida , Medição de Risco , Fatores de Risco , Hemorragia Uterina/diagnóstico , Hemorragia Uterina/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...